This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Indicated for long term female contraception.  Click here for Sayana®-Press (medroxyprogesterone acetate) Prescribing Information.  Adverse event reporting information can be found at the bottom of the page.

Sayana®-Press: Injectable Female Contraceptive

About Sayana-Press


​​​​Prescribe women a LARC* injection convenient for their lifestyle and one which has been built on over 30 years of contraception heritage1. Sayana-Press is a smart device with a once-every-13-weeks administration schedule (+/-1 week) for eligible women.2

Learn More

Self-administration

Explore Sayana-Press and watch the self-administration film.

Learn More

Managing Expectations

What can women expect from Sayana-Press?

For a list of adverse events please refer to the SPC

Understand More

Useful Resources

*Long acting reversible contraception
To read the full special warnings and precautions for use for Sayana-Press and see a full list of adverse events, refer to the Summary of Product Characteristics. The benefits of contraceptive options and their risks must be evaluated individually for each woman. If any of the conditions/risk factors mentioned is present, the benefits of Sayana-Press use should be weighed against the possible risks for each individual woman and discussed with the woman before she decides to start using it. In the event of aggravation, exacerbation or first appearance of any of these conditions or risk factors, the woman should contact her physician. The physician should then decide on whether Sayana-Press use should be discontinued.


References
  1. ​​​​​​Depo-Provera® Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/11121 Date accessed December 2020.
  2. Sayana-Press Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/27798/SPC/SAYANA+PRESS+104+mg+0.65+ml+suspension+for+injection/ Date accessed December 2020.
PP-SAY-GBR-0187. February 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No